Professional Documents
Culture Documents
Textbook Medical Biostatistics Fourth Edition Indrayan Ebook All Chapter PDF
Textbook Medical Biostatistics Fourth Edition Indrayan Ebook All Chapter PDF
Indrayan
Visit to download the full and correct content document:
https://textbookfull.com/product/medical-biostatistics-fourth-edition-indrayan/
More products digital (pdf, epub, mobi) instant
download maybe you interests ...
https://textbookfull.com/product/research-methods-for-medical-
graduates-1st-edition-abhaya-indrayan/
https://textbookfull.com/product/biostatistics-for-medical-and-
biomedical-practitioners-second-edition-julien-i-e-hoffman/
https://textbookfull.com/product/medical-terminology-complete-
fourth-edition-bruce-wingerd/
https://textbookfull.com/product/biological-and-medical-aspects-
of-electromagnetic-fields-fourth-edition-barnes/
Basic & Clinical Biostatistics Susan White
https://textbookfull.com/product/basic-clinical-biostatistics-
susan-white/
https://textbookfull.com/product/epidemiology-and-biostatistics-
an-introduction-to-clinical-research-bryan-kestenbaum/
https://textbookfull.com/product/intuitive-biostatistics-a-
nonmathematical-guide-to-statistical-thinking-4th-edition-harvey-
motulsky/
https://textbookfull.com/product/computational-and-
methodological-statistics-and-biostatistics-contemporary-essays-
in-advancement-andriette-bekker/
https://textbookfull.com/product/biostatistics-and-computer-
based-analysis-of-health-data-using-r-1st-edition-christophe-
lalanne/
Medical Biostatistics
Fourth Edition
Editor-in-Chief
Shein-Chung Chow, Ph.D., Professor, Department of Biostatistics and Bioinformatics,
Duke University School of Medicine, Durham, North Carolina
Series Editors
Byron Jones, Biometrical Fellow, Statistical Methodology, Integrated Information Sciences,
Novartis Pharma AG, Basel, Switzerland
Jen-pei Liu, Professor, Division of Biometry, Department of Agronomy,
National Taiwan University, Taipei, Taiwan
Karl E. Peace, Georgia Cancer Coalition, Distinguished Cancer Scholar, Senior Research Scientist
and Professor of Biostatistics, Jiann-Ping Hsu College of Public Health,
Georgia Southern University, Statesboro, Georgia
Bruce W. Turnbull, Professor, School of Operations Research and Industrial Engineering,
Cornell University, Ithaca, New York
Published Titles
Adaptive Design Methods in Clinical Basic Statistics and Pharmaceutical
Trials, Second Edition Statistical Applications, Second Edition
Shein-Chung Chow and Mark Chang James E. De Muth
Adaptive Designs for Sequential Bayesian Adaptive Methods for
Treatment Allocation Clinical Trials
Alessandro Baldi Antognini Scott M. Berry, Bradley P. Carlin,
and Alessandra Giovagnoli J. Jack Lee, and Peter Muller
Adaptive Design Theory and Bayesian Analysis Made Simple:
Implementation Using SAS and R, An Excel GUI for WinBUGS
Second Edition Phil Woodward
Mark Chang Bayesian Designs for Phase I–II
Advanced Bayesian Methods for Clinical Trials
Medical Test Accuracy Ying Yuan, Hoang Q. Nguyen,
Lyle D. Broemeling and Peter F. Thall
Analyzing Longitudinal Clinical Trial Data: Bayesian Methods for Measures
A Practical Guide of Agreement
Craig Mallinckrodt and Ilya Lipkovich Lyle D. Broemeling
Applied Biclustering Methods for Big Bayesian Methods for Repeated Measures
and High-Dimensional Data Using R Lyle D. Broemeling
Adetayo Kasim, Ziv Shkedy, Bayesian Methods in Epidemiology
Sebastian Kaiser, Sepp Hochreiter, Lyle D. Broemeling
and Willem Talloen
Bayesian Methods in Health Economics
Applied Meta-Analysis with R Gianluca Baio
Ding-Geng (Din) Chen and Karl E. Peace
Bayesian Missing Data Problems: EM,
Applied Surrogate Endpoint Evaluation Data Augmentation and Noniterative
Methods with SAS and R Computation
Ariel Alonso, Theophile Bigirumurame, Ming T. Tan, Guo-Liang Tian,
Tomasz Burzykowski, Marc Buyse, and Kai Wang Ng
Geert Molenberghs, Leacky Muchene,
Nolen Joy Perualila, Ziv Shkedy,
and Wim Van der Elst
Published Titles
Abhaya Indrayan
Rajeev Kumar Malhotra
CRC Press
Taylor & Francis Group
6000 Broken Sound Parkway NW, Suite 300
Boca Raton, FL 33487-2742
This book contains information obtained from authentic and highly regarded sources. Reasonable efforts have been made to publish reliable data and informa-
tion, but the author and publisher cannot assume responsibility for the validity of all materials or the consequences of their use. The authors and publishers have
attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form
has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may rectify in any future reprint.
Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic,
mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval
system, without written permission from the publishers.
For permission to photocopy or use material electronically from this work, please access www.copyright.com (http://www.copyright.com/) or contact the
Copyright Clearance Center, Inc. (CCC), 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400. CCC is a not-for-profit organization that provides licenses
and registration for a variety of users. For organizations that have been granted a photocopy license by the CCC, a separate system of payment has been arranged.
Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation without intent
to infringe.
Visit the Taylor & Francis Web site at
http://www.taylorandfrancis.com
and the CRC Press Web site at
http://www.crcpress.com
Contents
1. Medical Uncertainties.......................................................................................................................................................................1
1.1 Uncertainties in Health and Disease.....................................................................................................................................2
1.1.1 Uncertainties due to Intrinsic Variation..................................................................................................................2
1.1.1.1 Biologic Variability......................................................................................................................................2
1.1.1.2 Genetic Variability......................................................................................................................................3
1.1.1.3 Variation in Behavior and Other Host Factors........................................................................................3
1.1.1.4 Environmental Variability.........................................................................................................................3
1.1.1.5 Sampling Fluctuations................................................................................................................................3
1.1.2 Natural Variation in Assessment..............................................................................................................................4
1.1.2.1 Observer Variability....................................................................................................................................4
1.1.2.2 Variability in Treatment Strategies...........................................................................................................4
1.1.2.3 Instrument and Laboratory Variability...................................................................................................4
1.1.2.4 Imperfect Tools............................................................................................................................................4
1.1.2.5 Incomplete Information on the Patient....................................................................................................5
1.1.2.6 Poor Compliance with the Regimen.........................................................................................................5
1.1.3 Knowledge Limitations..............................................................................................................................................5
1.1.3.1 Epistemic Uncertainties..............................................................................................................................5
1.1.3.2 Chance Variability.......................................................................................................................................6
1.1.3.3 Diagnostic, Therapeutic, and Prognostic Uncertainties........................................................................6
1.1.3.4 Predictive and Other Uncertainties..........................................................................................................6
1.2 Uncertainties in Medical Research........................................................................................................................................7
1.2.1 Empiricism in Medical Research..............................................................................................................................7
1.2.1.1 Laboratory Experiments.............................................................................................................................7
1.2.1.2 Clinical Trials...............................................................................................................................................7
1.2.1.3 Surgical Procedures....................................................................................................................................7
1.2.1.4 Epidemiological Research..........................................................................................................................8
1.2.2 Elements of Minimizing the Impact of Uncertainties on Research....................................................................8
1.2.2.1 Proper Design..............................................................................................................................................8
1.2.2.2 Improved Medical Methods......................................................................................................................8
1.2.2.3 Analysis and Synthesis...............................................................................................................................9
1.3 Uncertainties in Health Planning and Evaluation..............................................................................................................9
1.3.1 Health Situation Analysis..........................................................................................................................................9
1.3.1.1 Identification of the Specifics of the Problem........................................................................................10
1.3.1.2 Magnitude of the Problem.......................................................................................................................10
1.3.1.3 Health Infrastructure...............................................................................................................................10
1.3.1.4 Feasibility of Remedial Steps...................................................................................................................11
1.3.2 Evaluation of Health Programs..............................................................................................................................11
1.4 Management of Uncertainties: About This Book..............................................................................................................11
1.4.1 Contents of the Book................................................................................................................................................12
1.4.1.1 Chapters......................................................................................................................................................12
1.4.1.2 Limitations and Strengths.......................................................................................................................13
1.4.1.3 New in the Fourth Edition.......................................................................................................................14
1.4.1.4 Unique Contribution of This Book.........................................................................................................14
ix
x Contents
3. Sampling Methods..........................................................................................................................................................................37
3.1 Sampling Concepts................................................................................................................................................................37
3.1.1 Advantages and Limitations of Sampling.............................................................................................................37
3.1.1.1 Sampling Fluctuations..............................................................................................................................37
3.1.1.2 Advantages of Sampling..........................................................................................................................38
3.1.1.3 Limitations of Sampling...........................................................................................................................38
3.1.2 Some Special Terms Used in Sampling.................................................................................................................38
3.1.2.1 Unit of Inquiry and Sampling Unit........................................................................................................38
3.1.2.2 Sampling Frame........................................................................................................................................39
3.1.2.3 Parameters and Statistics.........................................................................................................................39
3.1.2.4 Sample Size................................................................................................................................................39
3.1.2.5 Nonrandom and Random Sampling......................................................................................................39
3.1.2.6 Sampling Weight.......................................................................................................................................39
Contents xi
5. Medical Experiments......................................................................................................................................................................67
5.1 Basic Features of Medical Experiments..............................................................................................................................67
5.1.1 Statistical Principles of Experimentation..............................................................................................................68
5.1.1.1 Control Group............................................................................................................................................68
5.1.1.2 Randomization..........................................................................................................................................68
5.1.1.3 Replication..................................................................................................................................................69
5.1.2 Advantages and Limitations of Experiments.......................................................................................................69
5.1.2.1 Advantages.................................................................................................................................................69
5.1.2.2 Limitations.................................................................................................................................................70
5.2 Design of Experiments..........................................................................................................................................................70
5.2.1 Classical Designs: One-Way, Two-Way, and Factorial.........................................................................................71
5.2.1.1 One-Way Design........................................................................................................................................71
5.2.1.2 Two-Way Design........................................................................................................................................71
5.2.1.3 Interaction..................................................................................................................................................72
5.2.1.4 K-Way and Factorial Experiments...........................................................................................................73
5.2.2 Some Common Unconventional Designs..............................................................................................................74
5.2.2.1 Repeated Measures Design......................................................................................................................74
5.2.2.2 Crossover Design......................................................................................................................................75
5.2.2.3 Other Complex Designs...........................................................................................................................76
5.3 Choice of Sampling of Units for Laboratory Experiments...............................................................................................76
5.3.1 Choice of Experimental Unit...................................................................................................................................77
5.3.2 Sampling Methods in Laboratory Experiments...................................................................................................77
5.3.3 Choosing a Design of Experiment.........................................................................................................................77
5.3.4 Pharmacokinetic Studies.........................................................................................................................................78
References..........................................................................................................................................................................................78
Exercises.............................................................................................................................................................................................79
6. Clinical Trials...................................................................................................................................................................................81
6.1 Therapeutic Trials..................................................................................................................................................................81
6.1.1 Phases of a Clinical Trial.........................................................................................................................................81
6.1.1.1 Phase I Trial................................................................................................................................................81
6.1.1.2 Phase II Trial..............................................................................................................................................82
6.1.1.3 Phase III Trial.............................................................................................................................................82
6.1.1.4 Phase IV: Postmarketing Surveillance...................................................................................................83
6.1.2 Randomized Controlled Trials: Selection of Subjects.........................................................................................83
6.1.2.1 Selection of Participants for RCT............................................................................................................83
6.1.2.2 Control Group in a Clinical Trial............................................................................................................84
6.1.3 Randomization and Matching................................................................................................................................85
6.1.3.1 Randomization..........................................................................................................................................86
6.1.3.2 Matching.....................................................................................................................................................86
6.1.4 Methods of Random Allocation.............................................................................................................................87
6.1.4.1 Allocation Out of a Large Number of Available Subjects...................................................................87
6.1.4.2 Random Allocation of Consecutive Patients Coming to a Clinic......................................................87
6.1.4.3 Block, Cluster, and Stratified Randomization.......................................................................................88
Contents xiii
PROLOGUE 7
I. — DEUX HOMMES, DEUX CHIMÈRES 23
II. — LES CAVALIERS… 34
III. — … ET LEUR MONTURE 55
IV. — PROPOS ENTRE CIEL ET TERRE 64
V. — LE JOUR VIOLET 77
VI. — SUR LA PIERRE BRUNE 91
VII. — CEINTRAS ÉGARE SON OMBRE ET SA RAISON 101
VIII. — LA FACE AURÉOLÉE D’ÉTOILES 118
IX. — HEURES D’ATTENTE 130
X. — L’ÊTRE SE MONTRE 143
XI. — EXCURSIONS SOUTERRAINES 163
XII. — FAUX DÉPART 189
XIII. — L’AGONIE DE LA LUMIÈRE 206
XIV. — ÉCRIT SOUS LA DICTÉE DE LA MORT 226
ÉPILOGUE 233
ACHEVÉ D’IMPRIMER
Le vingt-sept mai mil neuf cent sept
PAR
ARRAULT ET Cie
A TOURS
pour le
MERCVRE
DE
FRANCE
*** END OF THE PROJECT GUTENBERG EBOOK LE PEUPLE DU
PÔLE ***
Updated editions will replace the previous one—the old editions will
be renamed.
1.D. The copyright laws of the place where you are located also
govern what you can do with this work. Copyright laws in most
countries are in a constant state of change. If you are outside the
United States, check the laws of your country in addition to the terms
of this agreement before downloading, copying, displaying,
performing, distributing or creating derivative works based on this
work or any other Project Gutenberg™ work. The Foundation makes
no representations concerning the copyright status of any work in
any country other than the United States.
• You pay a royalty fee of 20% of the gross profits you derive from
the use of Project Gutenberg™ works calculated using the
method you already use to calculate your applicable taxes. The
fee is owed to the owner of the Project Gutenberg™ trademark,
but he has agreed to donate royalties under this paragraph to
the Project Gutenberg Literary Archive Foundation. Royalty
payments must be paid within 60 days following each date on
which you prepare (or are legally required to prepare) your
periodic tax returns. Royalty payments should be clearly marked
as such and sent to the Project Gutenberg Literary Archive
Foundation at the address specified in Section 4, “Information
about donations to the Project Gutenberg Literary Archive
Foundation.”
• You comply with all other terms of this agreement for free
distribution of Project Gutenberg™ works.
1.F.
1.F.4. Except for the limited right of replacement or refund set forth in
paragraph 1.F.3, this work is provided to you ‘AS-IS’, WITH NO
OTHER WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED,
INCLUDING BUT NOT LIMITED TO WARRANTIES OF
MERCHANTABILITY OR FITNESS FOR ANY PURPOSE.
Please check the Project Gutenberg web pages for current donation
methods and addresses. Donations are accepted in a number of
other ways including checks, online payments and credit card
donations. To donate, please visit: www.gutenberg.org/donate.
Most people start at our website which has the main PG search
facility: www.gutenberg.org.